Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

David Rovinsky

Orthopaedic Surgery Lihue, HI Medical Doctor

NPI 1528163284 CMS profile 777042

3-3420 Kuhio Hwy, Suite B, Lihue, HI 96766

Open in the dashboard

General payments

$1,113,875

526 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, David Rovinsky of Lihue, HI is reported in the CMS Open Payments database as having received $1,113,875 across 526 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $115,060 60
2024 General $288,294 65
2023 General $144,294 60
2022 General $74,065 55
2021 General $83,538 58
2020 General $131,537 68
2019 General $277,087 160

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • David Rovinsky
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to David Rovinsky were reported at $115,060. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year David Rovinsky Orthopaedic Surgery median Middle half National median
2019 $277,087 $644 $140–$2,844 $163
2020 $131,537 $312 $75–$1,860 $114
2021 $83,538 $520 $117–$2,495 $132
2022 $74,065 $598 $128–$2,731 $149
2023 $144,294 $461 $128–$2,264 $160
2024 $288,294 $497 $134–$2,475 $164
2025 $115,060 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Smith+Nephew, Inc. $930,536 499 payments
  2. Zimmer Biomet Holdings, Inc. $182,693 18 payments
  3. Orthalign Inc $364 4 payments
  4. DePuy Synthes Sales Inc. $225 4 payments
  5. AxoGen $56 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $536,424 150 payments
  2. Consulting Fee $237,000 70 payments
  3. Travel and Lodging $171,053 135 payments
  4. Royalty or License $143,951 1 payment
  5. Acquisitions $12,881 1 payment
  6. Food and Beverage $12,565 169 payments
Products named General payments · program years 2019–2025
  1. REAL INTELLIGENCE $343,856 154 payments
  2. Navio Surgical System $201,247 112 payments
  3. JOURNEY II Recon Knees $106,848 64 payments
  4. Journey II XR $103,495 46 payments
  5. NAVIO $102,290 52 payments
  6. Journey II BCS $91,777 47 payments
  7. JOURNEY II Recon Knees $82,262 33 payments
  8. LEGION Revision $78,067 37 payments
  9. JII Unicondylar Knee System $56,552 22 payments
  10. POLARSTEM $48,934 14 payments
  11. Other $705,793 419 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 4 drugs

Part D claims

262

Median for Orthopedic Surgery: 203

Drug cost

$1,716

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Ibuprofen Generic 56 $563
Cefadroxil Generic 75 $550
Oxycodone Hcl Generic 72 $323
Ondansetron Hcl Generic 59 $280

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 28 billing codes

Paid by Medicare

$64,253

Medicare's payments for the services billed

Medicare patients

157

Average age 76

Services billed

419

76 women, 81 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 59%
Osteoporosis 19%
Chronic kidney disease 18%
Diabetes 17%
Cancer 17%
Ischemic heart disease 15%
Depression 10%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

526 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Hawaii

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record